Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration

por Bamias, A, Tzannis, K, Beuselinck, B, Oudard, S, Escudier, B, Diosynopoulos, D, Papazisis, K, Lang, H, Wolter, P, de Guillebon, E, Stravodimos, K, Chrisofos, M, Fountzilas, G, Elaidi, R-T, Dimopoulos, M A, Bamia, C
Publicado 2013

Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial

por de Guillebon, E., Jimenez, M., Mazzarella, L., Betsou, F., Stadler, P., Peták, I., Jeannot, E., Chanas, L., Servant, N., Marret, G., Duso, B.A., Legrand, F., Kornerup, K.N., Bernhart, S.H., Balogh, G., Dóczi, R., Filotás, P., Curigliano, G., Bièche, I., Guérin, J., Dirner, A., Neuzillet, C., Girard, N., Borcoman, E., Larbi Chérif, L., Tresca, P., Roufai, D.B., Dupain, C., Scholl, S., André, F., Fernandez, X., Filleron, T., Kamal, M., Le Tourneau, C.
Publicado 2021